Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-30 · accession 0001415889-21-003387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-02 | 2021-06-30 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $1.95 | +5,000 | 45.4K | +12% | +$9,750 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | A | A | 5,000 | $1.95 | 45,375 | D | — | — | (F1) Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c). |